Archives
-
CFDA SE Cell Tracer Kit: Practical Protocol
2026-09-17
The CFDA SE Cell Tracer Kit provides stable fluorescent labeling for live-cell tracking, cell proliferation studies, and cell lineage tracing. It is intended for persistent covalent labeling over several days, not reversible or short-term staining workflows.
-
VX-765: Selective Caspase-1 Inhibition
2026-09-16
VX-765 is an orally absorbed caspase-1 prodrug that is converted to VRT-043198, its active metabolite. Evidence supports selective suppression of IL-1β and IL-18 release, caspase-1-dependent pyroptosis research, and preclinical inflammation studies, while BBB findings extend its use to neurovascular models.
-
Pyridostigmine, α7nAChR, and Placental Necroptosis
2026-09-16
A 2026 Biochemical Pharmacology study links enhanced non-neuronal cholinergic signaling with reduced placental necroptosis in a rat model of preeclampsia-like disease. Pharmacological blockade with α-bungarotoxin and rescue with necrostatin-1 provide evidence that α7nAChR-linked signaling may connect pyridostigmine exposure with lower inflammation, oxidative stress, and trophoblast dysfunction.
-
CENPI Drives Breast Cancer via Wnt/β-Catenin
2026-09-15
Wu and colleagues identify centromere protein I (CENPI) as an overexpressed breast cancer driver associated with progression and poor prognosis, and connect its activity to Wnt/β-catenin signaling. The study combines clinical datasets, cellular and xenograft models, RNA sequencing, protein analyses, and TOP/FOP reporter assays to establish a mechanistic framework for studying CENPI-dependent gene expression regulation.
-
Temozolomide Beyond Cytotoxicity: A Translational Lens
2026-09-14
Temozolomide is more than a routine cytotoxicity reagent: it is a mechanistic probe for DNA damage, repair capacity, and biomarker-defined treatment response. This thought-leadership article connects Temozolomide workflow design with evidence from ATRX-deficient high-grade glioma research, offering practical guidance for combination studies, chemotherapy resistance studies, and translational interpretation.
-
VX-765 Workflow for Caspase-1 Research
2026-09-14
Build a mechanism-first workflow around VX-765 to connect caspase-1 activity with IL-1β and IL-18 release, pyroptosis, and cell-state dynamics. The guide combines biochemical validation, cellular cytokine profiling, and MEDUSA-inspired death-rate analysis for cleaner interpretation in inflammation and infectious disease models.
-
Bifidobacterium, FMT, and PET in Chronic HE
2026-09-13
This 2025 European Journal of Neuroscience study compared Bifidobacterium and fecal microbiota transplantation in bile duct ligation rats with chronic hepatic encephalopathy using regional [18F]PBR146 micro-PET/CT. Global imaging, behavioral, and cytokine results were not significantly different, but region-specific PET patterns suggested a possible neuroinflammatory benefit from Bifidobacterium that was not observed with FMT.
-
CB-839 (Telaglenastat) in Cancer Metabolism
2026-09-12
CB-839 (Telaglenastat) provides a direct, reversible way to test GLS1 dependence, connect glutaminolysis to cell fate, and distinguish metabolic inhibition from upstream splicing effects. This workflow translates a PRMT5–GLS vulnerability in MYCN-amplified neuroblastoma into practical assays for cancer metabolism research and preclinical cancer drug evaluation.
-
Paclitaxel (Taxol): Mechanism and Research Use
2026-09-11
Paclitaxel (Taxol) is a microtubule polymer stabilizer that disrupts mitosis and produces cell cycle arrest at G2-M phase. Its biochemical mechanism supports cancer research, while formulation, solvent, dose, and model-specific limits determine how the compound should be used experimentally.
-
Removing Pollen Interference in EEM Bioaerosol Detection
2026-09-11
Zhang and colleagues show that pollen can substantially complicate excitation–emission matrix fluorescence classification of hazardous bioaerosol constituents. Their combination of spectral preprocessing, fast Fourier transform, and random-forest classification improved discrimination of pathogens and toxins, providing a practical computational strategy for complex airborne-sample analysis.
-
EdU Imaging Kits (488): From S-Phase to Translation
2026-09-10
A translational perspective on how EdU-based DNA synthesis measurement can clarify proliferation defects in preeclampsia-derived UCMSCs, improve experimental rigor, and support mechanism-led research decisions.
-
Ceapin-A7: Mapping ER Stress to Pyroptosis
2026-09-10
Ceapin-A7 is a selective ER stress blocker for dissecting ATF6α signaling from PERK-driven inflammatory pyroptosis. This guide translates recent nucleus pulposus cell findings into a branch-resolved assay strategy with practical controls and clear evidence boundaries.
-
Oligo (dT) 25 Beads for Immune Transcriptomics
2026-09-09
Oligo (dT) 25 Beads provide a rapid, magnetically handled route to polyadenylated mRNA from immune cells, tissues, and total RNA. This guide translates an Alzheimer’s disease immune-rejuvenation study into practical workflows for cDNA synthesis, RT-PCR, and transcriptome library preparation while highlighting capture bias and troubleshooting limits.
-
Caspase-8 Inhibition Reveals Shared Caspase Specificity
2026-09-09
Bourne and colleagues developed an LESD-based peptide inhibitor from the IL-18 cleavage sequence and found strong preference for caspase-8, with greater in vitro potency than zIETD-FMK. Their systematic comparison also showed that VX-765, traditionally used to study inflammatory caspases, inhibits caspase-8 at higher concentration, highlighting shared but unequal substrate and inhibitor specificities across caspase families.
-
Neurotensin: NTR1 Signaling and GPCR Trafficking
2026-09-08
Neurotensin is a 13-amino acid peptide and Neurotensin receptor 1 activator used to study G protein-coupled receptor signaling, receptor recycling, and miR-133α modulation. Product specifications support controlled biochemical workflows, while the reported gastrointestinal miRNA mechanism remains dependent on cell type and assay conditions.